Are the effects of psychomotor stimulant drugs on hyperactive children really paradoxical?

Medical Hypotheses
|July 1, 1977
PubMed

Insights

Amphetamine-like compounds improve attention in hyperactive children by increasing focus. This enhanced concentration aids sustained tasks but may hinder cognitive strategy changes, linked to central dopaminergic mechanisms.

Area of Science:

  • Neuroscience
  • Psychopharmacology
  • Developmental Psychology

Background:

  • Hyperactivity in children is often associated with attention deficits.
  • Stimulant medications, like amphetamines, are commonly prescribed for attention-deficit/hyperactivity disorder (ADHD).
  • The precise mechanisms by which these drugs affect attention remain under investigation.

Purpose of the Study:

  • To explore the relationship between amphetamine-induced stereotyped behavior and improved attention in hyperactive children.
  • To investigate how changes in attentional focus, induced by amphetamines, impact task performance.
  • To link these behavioral effects to the underlying central dopaminergic system.

Main Methods:

  • The study postulates a mechanism based on existing literature and theoretical frameworks.
  • It conceptualizes drug effects on attention as a form of "focusing."
  • The proposed mechanism involves the functioning of central dopaminergic pathways.

Main Results:

  • Amphetamine-like compounds may improve attention in hyperactive children through a normal action producing stereotyped behavior.
  • This stereotyped behavior is conceptualized as increased attentional "focus."
  • Enhanced focus is hypothesized to benefit tasks requiring sustained concentration but impair tasks needing cognitive flexibility.

Conclusions:

  • The observed improvements in attention with amphetamine-like compounds in hyperactive children may stem from their ability to induce stereotyped behaviors.
  • This attentional focusing effect has differential impacts on cognitive tasks, aiding sustained attention while potentially hindering strategy reversal.
  • Central dopaminergic mechanisms are implicated as the neurobiological basis for these observed behavioral and cognitive effects.

Related Concept Videos

Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants


Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Adrenergic Agonists: Indirect-Acting Agents01:25

Adrenergic Agonists: Indirect-Acting Agents

Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
Stimulants01:29

Stimulants

Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.